Is AYRO still undervalued?

The valuation of AYRO (Gyrodyne, LLC) remains uncertain due to the lack of available P/E, P/B, and P/S ratios. However, the recent land sale agreement and strategic liquidation plan suggest that the company may be approaching a value realization point. 1. **Land Sale Agreement Impact**: The agreement to sell 49 acres of land for $28.7 million represents a significant asset monetization. This sale increases the estimated net asset value in liquidation (NAV) to approximately $32.6 million, or $14.83 per share, as of June 30, 2025. This is a substantial increase from the previous NAV of $30.8 million, or $14.01 per share. This indicates a potential revaluation opportunity as the company advances in its strategic liquidation plan. 2. **Market Reaction and Strategic Plan**: The stock price of AYRO surged by 13.3% following the announcement of the land sale agreement. This market optimism may reflect investor confidence in the company's ability to execute its strategic plan and maximize shareholder value. The agreement to sell the parcel in Smithtown, New York, as part of a strategic liquidation plan, is expected to enhance the marketability and value of adjacent industrial properties. This could lead to further value realization as the company proceeds with the sale of its remaining real property assets. 3. **Financial Metrics**: Although the P/E, P/B, and P/S ratios are not currently available, the company's financial statements indicate a loss per share of -$2.53 over the last 12 months with a revenue of $2.74 million and an operating margin of -126.72%. These figures suggest that the company has been unprofitable, which may have affected its valuation metrics. However, the land sale agreement could turn the tide, making the company more attractive to investors. In conclusion, while AYRO's valuation remains absent without P/E, P/B, and P/S ratios, the recent positive developments, including the land sale agreement and increased NAV, suggest that the company may be approaching a valuation inflection point. Investors should monitor the company's progress in selling its remaining assets and the market's reaction to these developments. If the company successfully completes its strategic plan, it could lead to a revaluation and potential upside in the stock price.